Placental tissue grafts and methods of preparing and using the same

US9533011B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9533011-B2
Application numberUS-201414171511-A
CountryUS
Kind codeB2
Filing dateFeb 3, 2014
Priority dateSep 7, 2007
Publication dateJan 3, 2017
Grant dateJan 3, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing a de-epithelialized multilayer laminate comprising at least one amnion layer which method comprises: placing at least one modified amnion layer comprising a first side which is an exposed basement membrane and a second side which retains a fibroblast cellular layer in contact with a second layer such that the amnion layer is positioned to contact its fibroblast cellular layer with the second layer; optionally adding one or more additional layers to said amnion or to said second layer; and dehydrating and laminating the layers under heated conditions; wherein the second layer is selected from the group consisting of amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, a biocellulose polymer or copolymers, purified small intestinal submucosa, bladder acellular matrix, cadaveric fascia, and a combination thereof. 2. The method of claim 1 , wherein the second layer is amnion or chorion. 3. The method of claim 1 , wherein the dehydrating and laminating are conducted in a drying fixture. 4. The method of claim 3 , wherein the surface of the drying fixture has a plurality of grooves that defines the outer contours of each of the plurality of placenta. 5. The method of claim 3 , wherein the drying fixture includes a texture or design adapted to emboss such texture or design into the basement membrane during dehydration. 6. The method of claim 1 , wherein the heated conditions comprise a temperature of between 35° C. and 50° C. and a period of between 30 and 120 minutes. 7. The method of claim 1 , wherein the one or more additional layers comprises amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, purified xenograft Type-1 collagen, biocellulose polymers or copolymers, biocompatible synthetic polymer or copolymer films, purified small intestinal submucosa, bladder acellular matrix, cadaveric fascia, or any combination thereof. 8. The method of claim 1 , wherein the one or more additional layers comprises chorion, amnion, or a combination thereof.

Assignees

Inventors

Classifications

  • Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution · CPC title

  • characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

  • Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof · CPC title

  • Methods of surface bonding and/or assembly therefor · CPC title

  • Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9533011B2 cover?
Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the base…
Who is the assignee on this patent?
Mimedx Group Inc
What technology area does this patent fall under?
Primary CPC classification A61L27/3683. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).